DE69518706D1 - Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom - Google Patents
Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von GlaukomInfo
- Publication number
- DE69518706D1 DE69518706D1 DE69518706T DE69518706T DE69518706D1 DE 69518706 D1 DE69518706 D1 DE 69518706D1 DE 69518706 T DE69518706 T DE 69518706T DE 69518706 T DE69518706 T DE 69518706T DE 69518706 D1 DE69518706 D1 DE 69518706D1
- Authority
- DE
- Germany
- Prior art keywords
- glaucoma
- hydrogen atom
- medicament
- manufacture
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15450494A JP4063341B2 (ja) | 1994-07-06 | 1994-07-06 | 緑内障治療剤及び眼圧降下剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69518706D1 true DE69518706D1 (de) | 2000-10-12 |
DE69518706T2 DE69518706T2 (de) | 2001-05-23 |
Family
ID=15585694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69518706T Expired - Fee Related DE69518706T2 (de) | 1994-07-06 | 1995-06-14 | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom |
Country Status (8)
Country | Link |
---|---|
US (1) | US5658950A (de) |
EP (1) | EP0695545B1 (de) |
JP (1) | JP4063341B2 (de) |
KR (1) | KR100342367B1 (de) |
CN (1) | CN1077790C (de) |
AT (1) | ATE196080T1 (de) |
CA (1) | CA2152191C (de) |
DE (1) | DE69518706T2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0813878B1 (de) * | 1996-06-17 | 2002-02-06 | Mitsubishi Chemical Corporation | Mittel zur Beschleunigung des Tränenflusses enthaltend einen Serotonin-Liganden, insbesondere Aminoalkoxybibenzyle |
CA2348879A1 (en) | 1998-11-02 | 2000-05-11 | Welfide Corporation | Pyrrolidine compound and pharmaceutical use thereof |
AU2001230589A1 (en) * | 2000-02-09 | 2001-08-20 | Mitsubishi Pharma Corporation | Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases |
EP1974738A3 (de) * | 2000-02-29 | 2008-12-17 | Alcon, Inc. | Diagnose- und Behandlungsverfahren für Glaukome |
WO2003026636A1 (fr) * | 2001-09-26 | 2003-04-03 | Mitsubishi Pharma Corporation | Inhibiteurs de thrombus/thrombogenese |
KR20050025628A (ko) | 2002-07-19 | 2005-03-14 | 바이오비트럼 에이비 | 5-ht2a 수용체 관련 장애의 치료를 위한 신규피페라지닐-피라지논 유도체 |
KR101384827B1 (ko) * | 2005-07-29 | 2014-04-15 | 미쓰비시 타나베 파마 코퍼레이션 | 소형화 염산 사포그릴레이트 경구 투여 제제 |
JP6696465B2 (ja) | 2017-03-16 | 2020-05-20 | 株式会社安川電機 | コントロールシステム、コントローラ及び制御方法 |
JP2022059092A (ja) * | 2019-02-15 | 2022-04-13 | アステラス製薬株式会社 | 眼圧下降用医薬組成物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5832847A (ja) * | 1981-08-20 | 1983-02-25 | Mitsubishi Chem Ind Ltd | (3−アミノプロポキシ)ビベンジル類 |
JPS6313427A (ja) | 1986-07-04 | 1988-01-20 | Ricoh Co Ltd | 通信装置 |
-
1994
- 1994-07-06 JP JP15450494A patent/JP4063341B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-02 US US08/458,687 patent/US5658950A/en not_active Expired - Fee Related
- 1995-06-14 AT AT95109239T patent/ATE196080T1/de active
- 1995-06-14 DE DE69518706T patent/DE69518706T2/de not_active Expired - Fee Related
- 1995-06-14 EP EP95109239A patent/EP0695545B1/de not_active Expired - Lifetime
- 1995-06-20 CA CA002152191A patent/CA2152191C/en not_active Expired - Fee Related
- 1995-07-06 KR KR1019950019812A patent/KR100342367B1/ko not_active IP Right Cessation
- 1995-07-06 CN CN95108158A patent/CN1077790C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4063341B2 (ja) | 2008-03-19 |
CA2152191A1 (en) | 1996-01-07 |
CA2152191C (en) | 2006-10-10 |
KR960003719A (ko) | 1996-02-23 |
ATE196080T1 (de) | 2000-09-15 |
EP0695545A1 (de) | 1996-02-07 |
JPH0820531A (ja) | 1996-01-23 |
DE69518706T2 (de) | 2001-05-23 |
US5658950A (en) | 1997-08-19 |
EP0695545B1 (de) | 2000-09-06 |
CN1077790C (zh) | 2002-01-16 |
CN1120934A (zh) | 1996-04-24 |
KR100342367B1 (ko) | 2002-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69716226D1 (de) | Difluoroprostaglandin-Derivate und ihre Anwendung | |
ATE294577T1 (de) | Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen | |
DE69500660D1 (de) | Ophthalmische Zusammensetzung enthaltend ein 1,5-Benzoxathiepin-Derivat zur Behandlung von Glaukoma | |
ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
DE69518706D1 (de) | Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom | |
ATE223718T1 (de) | Verwendung von riminophenazin zur behandlung von mdr-resistenz | |
DE69929362D1 (de) | verwendung von 1,4-benzothiazepinen zur Herstellung eines Medikaments ZUR BEHANDLUNG DER VORHOF-FIBRILLATION | |
ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
ATE284684T1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
DE3750464D1 (de) | Pharmazeutisches Präparat zur Behandlung des Katarakts. | |
DE69713648D1 (de) | Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten | |
ATE160566T1 (de) | Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel | |
ATE181503T1 (de) | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution | |
DE60005525D1 (de) | 2-aminotetraline zur behandlung von glaukom | |
ATE426587T1 (de) | Neue phenolderivate und praventives/therapeutisches antitrypanosomenmittel, das diese als wirkstoffe enthalt | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
KR950704322A (ko) | 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders) | |
DE69327077D1 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
DE69722630D1 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen | |
ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
DE69424677D1 (de) | Präparat zur behandlung der drogenabhängigkeit | |
MX9708031A (es) | Sales de 3-fenil-1,4-dialquil-1,2,4-triazolio y su uso como antidepresivos. | |
TW200511994A (en) | Novel compounds and therapeutic uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MEI CO.,LTD., AMAGASAKI, HYOGO, JP |
|
8339 | Ceased/non-payment of the annual fee |